LAA Thrombus | ||||
---|---|---|---|---|
All Subjects | Present | Absent | P value | |
N = 261 | N = 17 | N = 244 | ||
Age (years) | 65 ± 12 | 69 ± 10 | 65 ± 12 | 0.190 |
Age ≥ 75 years | 56 (21) | 5 (29) | 51 (21) | 0.409 |
Age ≥ 65 years | 150 (58) | 13 (76) | 137 (56) | 0.101 |
Female | 79 (30) | 5 (29) | 74 (30) | 0.937 |
Hypertension | 196 (75) | 15 (88) | 181 (74) | 0.195 |
Diabetes mellitus | 67 (26) | 7 (41) | 60 (25) | 0.130 |
Congestive heart failure | 102 (39) | 13 (76) | 89 (36) | 0.001 |
History of stroke or TIA | 35 (13) | 5 (29) | 30 (12) | 0.045 |
Vascular disease | 53 (20) | 5 (29) | 48 (20) | 0.334 |
Dyslipidemia | 126 (48) | 9 (53) | 117 (48) | 0.691 |
BMI (Kg/m2) | 31.4 ± 8.5 | 28 ± 5.7 | 31.7 ± 8.7 | 0.091 |
Creatinine (mg/dL) | 1.3 ± 1.1 | 1.9 ± 1.9 | 1.2 ± 1.0 | 0.076* |
Warfarin | 124 (48) | 10 (59) | 114 (47) | 0.334 |
NOACs | 48 (18) | 3 (18) | 45 (18) | 0.935 |
Antiplatelet | 140 (54) | 9 (53) | 131 (54) | 0.952 |
CHADS2 score | 1.9 ± 1.3 | 2.9 ± 1.3 | 1.8 ± 1.3 | 0.001* |
CHA2DS2-VASc Score | 3.0 ± 1.8 | 4.4 ± 1.6 | 3.0 ± 1.8 | 0.001* |
AF chronicity | 0.789 | |||
Paroxysmal | 67 (26) | 5 (29) | 62 (25) | |
Persistent | 107 (41) | 7 (41) | 100 (41) | |
Permanent | 34 (13) | 3 (18) | 31 (13) | |
Unknown | 53 (20) | 2 (12) | 51 (21) | |
LVEF (%) | 47 ± 17 | 34 ± 13 | 48 ± 17 | 0.002 |
LVEDV index (mL/m2) | 54 ± 29 | 69 ± 34 | 53 ± 29 | 0.054 |
LV mass index (g/m2) | 103 ± 41 | 113 ± 29 | 102 ± 41 | 0.311 |
LA volume index (mL/m2) | 33 ± 16 | 42 ± 18 | 33 ± 16 | 0.035 |
Degree of SEC (scale 0–4) | 0.6 ± 1.1 | 3.0 ± 1.1 | 0.4 ± 0.9 | <0.001* |
SEC present | 85 (33) | 17 (100) | 68 (28) | <0.001 |
LAA emptying velocity (cm/s) | 42 ± 22 | 25 ± 11 | 44 ± 22 | 0.001 |
BNP (pg/mL) | 409 ± 554 | 775 ± 678 | 384 ± 537 | 0.001* |